Transactions
Showing results for
Healthcare
and
Japan
1 to 16 of 29
Industrials
Advised
- Sumitomo Bakelite Co., Ltd.
on its acquisition of remaining 76.95% stake in
- Kawasumi Laboratories, Inc.
Value: ¥27bn
Healthcare
Advised
- Matsumoto kiyoshi Holdings
on the acquisition of a minority stake in
- Cocokara Fine Inc.
Value: $353m
Healthcare
Advised
- Taisho Pharmaceutical Holdings
on the acquisition of a minority stake in
- DHG Pharmaceutical
Value: ¥16bn
Healthcare
Advised
- Sumitomo Bakelite
on the acquisition of shares in
- Kawasumi Laboratories
Healthcare
Advised
- Chiral Technologies
on the acquisition of
- Arbor Biosciences
Healthcare
Advised
- Taisho Pharmaceuticals
on the acquisition of
- UPSA from Bristol-Myers Squibb Company
Value: ¥1.6bn
Healthcare
Advised
- Alfresa
on the acquisition of
- Daiichi Sankyo’s long-listed products
Healthcare
Advised
- Accuron MedTech Group and other Vendors
on the sale of Verdus Laboratories Pte Ltd to
- Sekisui Chemical Co Ltd
Healthcare
Advised
- Fujifilm
on the acquisition of
- Wako Pure Chemical Industries
Value: ¥252.3bn
Healthcare
Advised
- Omron Healthcare
on the sale of
- OMRON COLIN to Fukuda Denshi
Value: ¥1.9bn
Healthcare
Advised
- Paramount Bed Holdings
on the sale of
- Corona Medical
Healthcare
Advised
- Kobayashi Pharmaceutical Co., Ltd.
on the acquisition of
- Berlin Industries, Inc
Healthcare
Advised
- Taisho Pharmaceutical Holdings
on the acquisition of 25% shares in
- DHG Pharmaceutical
Healthcare
Advised
- SMS and Mitsui & Co
on the acquisition of
- MIMS group
Value: $250M
For important information regarding transactions, please see our disclaimer.
